News
Recommendation based on Phase 3 RATIONALE-315 study, in which TEVIMBRA demonstrated clinically meaningful and statistically significant improvement in event-free survival and major pathological respon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback